Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001378263 | SCV001575798 | pathogenic | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2025-01-06 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 173 of the MCCC2 protein (p.Ser173Leu). This variant is present in population databases (rs752866557, gnomAD 0.006%). This missense change has been observed in individual(s) with 3-methylcrotonyl-CoA carboxylase deficiency (PMID: 11181649, 22642865). ClinVar contains an entry for this variant (Variation ID: 203803). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt MCCC2 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects MCCC2 function (PMID: 11181649). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV001378263 | SCV002811400 | likely pathogenic | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2024-04-26 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001378263 | SCV004194347 | likely pathogenic | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2024-02-15 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001378263 | SCV002084291 | likely pathogenic | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2021-08-17 | no assertion criteria provided | clinical testing |